News | March 12, 2025
Aster DM Healthcare promoters reduce share pledge from 99% to 41%
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
Overall investment in the US facility is estimated around US$50 million
Zydus will carry out early-stage development, animal immunogenicity studies and regulatory preclinical toxicology studies for this combination vaccine
Amgen India investment totals $200 million through 2025
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
Cipla Limited has received final approval from the USFDA for the New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’
Krishna Institute of Medical Sciences Ltd enters into agreement with Splendid Hospitals
Zongertinib would be the first orally administered, targeted therapy for previously treated patients with HER2 (ERBB2)-mutant advanced non-small cell lung cancer (NSCLC), if approved
This rating reflects Lupin's leadership in environmental transparency and performance
No safety signals related to the vaccine candidate were identified
Subscribe To Our Newsletter & Stay Updated
